A citation-based method for searching scientific literature

Peter J Goadsby, Richard B Lipton, Michel D Ferrari. N Engl J Med 2002
Times Cited: 1227







List of co-cited articles
739 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Pathophysiology of Migraine: A Disorder of Sensory Processing.
Peter J Goadsby, Philip R Holland, Margarida Martins-Oliveira, Jan Hoffmann, Christoph Schankin, Simon Akerman. Physiol Rev 2017
621
22


Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.
Jes Olesen, Hans-Christoph Diener, Ingo W Husstedt, Peter J Goadsby, David Hall, Ulrich Meier, Stephane Pollentier, Lynna M Lesko. N Engl J Med 2004
859
15


CGRP as the target of new migraine therapies - successful translation from bench to clinic.
Lars Edvinsson, Kristian Agmund Haanes, Karin Warfvinge, Diana N Krause. Nat Rev Neurol 2018
328
13

CGRP may play a causative role in migraine.
L H Lassen, P A Haderslev, V B Jacobsen, H K Iversen, B Sperling, J Olesen. Cephalalgia 2002
621
12

Migraine prevalence, disease burden, and the need for preventive therapy.
R B Lipton, M E Bigal, M Diamond, F Freitag, M L Reed, W F Stewart. Neurology 2007
12

Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks.
Farooq Husain Maniyar, Till Sprenger, Teshamae Monteith, Christoph Schankin, Peter James Goadsby. Brain 2014
247
10

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.
R B Lipton, W F Stewart, S Diamond, M L Diamond, M Reed. Headache 2001
9




Premonitory symptoms in migraine: an electronic diary study.
N J Giffin, L Ruggiero, R B Lipton, S D Silberstein, J F Tvedskov, J Olesen, J Altman, P J Goadsby, A Macrae. Neurology 2003
395
8

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
Stewart Tepper, Messoud Ashina, Uwe Reuter, Jan L Brandes, David Doležil, Stephen Silberstein, Paul Winner, Dean Leonardi, Daniel Mikol, Robert Lenz. Lancet Neurol 2017
319
8

Diencephalic and brainstem mechanisms in migraine.
Simon Akerman, Philip R Holland, Peter J Goadsby. Nat Rev Neurosci 2011
320
8

Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.
Tony W Ho, Kathryn M Connor, Ying Zhang, Eric Pearlman, Janelle Koppenhaver, Xiaoyin Fan, Christopher Lines, Lars Edvinsson, Peter J Goadsby, David Michelson. Neurology 2014
154
7


Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Eva Cernuda-Morollón, Davinia Larrosa, César Ramón, Juan Vega, Pablo Martínez-Camblor, Julio Pascual. Neurology 2013
202
7

Calcitonin gene-related peptide: physiology and pathophysiology.
F A Russell, R King, S-J Smillie, X Kodji, S D Brain. Physiol Rev 2014
488
7



Blocking CGRP in migraine patients - a review of pros and cons.
Marie Deen, Edvige Correnti, Katharina Kamm, Tim Kelderman, Laura Papetti, Eloisa Rubio-Beltrán, Simone Vigneri, Lars Edvinsson, Antoinette Maassen Van Den Brink. J Headache Pain 2017
123
6


Brain stem activation in spontaneous human migraine attacks.
C Weiller, A May, V Limmroth, M Jüptner, H Kaube, R V Schayck, H H Coenen, H C Diener. Nat Med 1995
6

The migraine postdrome: An electronic diary study.
Nicola J Giffin, Richard B Lipton, Stephen D Silberstein, Jes Olesen, Peter J Goadsby. Neurology 2016
78
7

ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
David W Dodick, Messoud Ashina, Jan Lewis Brandes, David Kudrow, Michel Lanteri-Minet, Vera Osipova, Kerry Palmer, Hernan Picard, Daniel D Mikol, Robert A Lenz. Cephalalgia 2018
220
6

Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.
Virginia L Stauffer, David W Dodick, Qi Zhang, Jeffrey N Carter, Jessica Ailani, Robert R Conley. JAMA Neurol 2018
207
6

Fremanezumab for the Preventive Treatment of Chronic Migraine.
Stephen D Silberstein, David W Dodick, Marcelo E Bigal, Paul P Yeung, Peter J Goadsby, Tricia Blankenbiller, Melissa Grozinski-Wolff, Ronghua Yang, Yuju Ma, Ernesto Aycardi. N Engl J Med 2017
296
6

Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial.
Vladimir Skljarevski, Manjit Matharu, Brian A Millen, Michael H Ossipov, Byung-Kun Kim, Jyun Yan Yang. Cephalalgia 2018
186
6

Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
David W Dodick, Stephen D Silberstein, Marcelo E Bigal, Paul P Yeung, Peter J Goadsby, Tricia Blankenbiller, Melissa Grozinski-Wolff, Ronghua Yang, Yuju Ma, Ernesto Aycardi. JAMA 2018
187
6



Wiping Out CGRP: Potential Cardiovascular Risks.
Antoinette MaassenVanDenBrink, Joris Meijer, Carlos M Villalón, Michel D Ferrari. Trends Pharmacol Sci 2016
123
6

Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study.
Holland C Detke, Peter J Goadsby, Shufang Wang, Deborah I Friedman, Katherine J Selzler, Sheena K Aurora. Neurology 2018
184
6

Migraine and cardiovascular disease: systematic review and meta-analysis.
Markus Schürks, Pamela M Rist, Marcelo E Bigal, Julie E Buring, Richard B Lipton, Tobias Kurth. BMJ 2009
474
6



CGRP and its receptors provide new insights into migraine pathophysiology.
Tony W Ho, Lars Edvinsson, Peter J Goadsby. Nat Rev Neurol 2010
310
6

Pathophysiology of migraine.
Daniela Pietrobon, Michael A Moskowitz. Annu Rev Physiol 2013
370
6


Migraine is first cause of disability in under 50s: will health politicians now take notice?
Timothy J Steiner, Lars J Stovner, Theo Vos, R Jensen, Z Katsarava. J Headache Pain 2018
237
5


Migraine and risk of cardiovascular diseases: Danish population based matched cohort study.
Kasper Adelborg, Szimonetta Komjáthiné Szépligeti, Louise Holland-Bill, Vera Ehrenstein, Erzsébet Horváth-Puhó, Victor W Henderson, Henrik Toft Sørensen. BMJ 2018
108
5

Mechanisms of migraine aura revealed by functional MRI in human visual cortex.
N Hadjikhani, M Sanchez Del Rio, O Wu, D Schwartz, D Bakker, B Fischl, K K Kwong, F M Cutrer, B R Rosen, R B Tootell,[...]. Proc Natl Acad Sci U S A 2001
953
5

Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine.
Padhraig Gormley, Verneri Anttila, Bendik S Winsvold, Priit Palta, Tonu Esko, Tune H Pers, Kai-How Farh, Ester Cuenca-Leon, Mikko Muona, Nicholas A Furlotte,[...]. Nat Genet 2016
303
5

Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study.
Bernice Kuca, Stephen D Silberstein, Linda Wietecha, Paul H Berg, Gregory Dozier, Richard B Lipton. Neurology 2018
118
5

A Controlled Trial of Erenumab for Episodic Migraine.
Peter J Goadsby, Uwe Reuter, Yngve Hallström, Gregor Broessner, Jo H Bonner, Feng Zhang, Sandhya Sapra, Hernan Picard, Daniel D Mikol, Robert A Lenz. N Engl J Med 2017
368
5

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine.
David J Hewitt, Sheena K Aurora, David W Dodick, Peter J Goadsby, Yang Joy Ge, Robert Bachman, Donna Taraborelli, Xiaoyin Fan, Christopher Assaid, Christopher Lines,[...]. Cephalalgia 2011
189
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.